scientific-skills/venue-templates/references/cell_press_style.md
Comprehensive writing guide for Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cell Reports, and other Cell Press journals.
Last Updated: 2024
Cell Press journals emphasize mechanistic depth, rigorous experimentation, and biological insight. Unlike Nature/Science, which prioritize broad accessibility, Cell papers are written for biologists who appreciate technical detail and comprehensive data.
"Cell papers tell a complete mechanistic story with exhaustive experimental support."
Primary Goal: Provide deep biological insight with extensive experimental validation that advances understanding of fundamental mechanisms.
Cell Press has several distinctive elements not found in other journals:
Cell uses "Summary" instead of "Abstract" - functionally similar but emphasizes synthesis.
A visual summary appearing on the table of contents. This is mandatory for all Cell Press journals.
A 30-50 word "elevator pitch" for the electronic table of contents.
3-4 bullet points (≤85 characters each) capturing key findings.
A one-sentence summary of the paper.
| Characteristic | Description |
|---|---|
| Technical | Appropriate jargon for the field |
| Mechanistic | Focus on how and why, not just what |
| Comprehensive | Thorough exploration of the question |
| Data-rich | Extensive experimental support |
| Precise | Exact terminology and quantification |
Cellular senescence is a stress response that arrests proliferation and
promotes tissue remodeling, but the mechanisms controlling senescent cell
fate remain unclear. Here, we identify the transcription factor FOXO4 as a
critical regulator of senescent cell viability. FOXO4 is highly expressed
in senescent cells and sequesters p53 away from mitochondria, preventing
apoptosis. Using a cell-penetrating peptide that disrupts FOXO4-p53
interaction, we selectively induce senescent cell apoptosis in vitro and
in vivo. Administration of this peptide to aged mice restores fitness, fur
density, and renal function. These findings reveal FOXO4-p53 as a senescence
vulnerability and establish proof-of-concept for targeted senolytic
interventions in aging.
A single-panel visual summary for the table of contents that captures the entire paper's message.
Typical Graphical Abstract Components:
1. Starting point (cell, organism, condition)
2. Intervention/treatment (arrows, symbols)
3. Key measurement or observation
4. Outcome/conclusion (visual representation)
5. Minimal text labels connecting elements
"Graphical abstract showing: Left panel - normal cells with FOXO4 (blue)
and p53 (green) separate. Center panel - senescent cells with FOXO4
binding p53, preventing apoptosis. Right panel - FOXO4 peptide disrupts
interaction, allowing p53 to reach mitochondria, triggering apoptosis.
Arrow at bottom showing aged mouse → treatment → rejuvenated mouse."
3-4 bullet points, each ≤85 characters (including spaces)
• FOXO4 is selectively expressed in senescent cells
• FOXO4 sequesters p53, preventing senescent cell apoptosis
• A FOXO4-targeting peptide induces selective senescent cell death
• Senolytic peptide treatment restores function in aged mice
30-50 words for the electronic table of contents
Baar et al. identify FOXO4 as a vulnerability of senescent cells and
develop a peptide that induces targeted apoptosis of senescent cells.
Treatment of aged mice with this senolytic peptide restores fitness
and organ function.
Paragraph 1: Biological Context
Paragraphs 2-3: State of the Field
Paragraph 4: The Gap
Paragraph 5: Your Approach
Final Paragraph: Key Findings Preview
Cellular senescence is characterized by stable cell-cycle arrest, profound
chromatin alterations, and a complex secretory phenotype known as the
senescence-associated secretory phenotype (SASP) (Coppé et al., 2008;
Rodier and Campisi, 2011). Senescent cells accumulate with age and at
sites of pathology, where they can drive tissue dysfunction through
SASP-mediated inflammation and disruption of tissue architecture (van
Deursen, 2014). The targeted elimination of senescent cells—senolysis—has
emerged as a promising therapeutic strategy, with genetic and pharmacological
approaches demonstrating benefits in mouse models of aging and age-related
disease (Baker et al., 2011, 2016; Chang et al., 2016).
Cell papers typically have 5-8 results sections, each with a descriptive subheading:
Results
├── Section 1: Discovery of the phenomenon
├── Section 2: Characterization of the mechanism
├── Section 3: Identification of molecular players
├── Section 4: Functional validation
├── Section 5: In vivo confirmation
├── Section 6: Therapeutic proof-of-concept
└── Section 7: Broader implications
Cell uses declarative subheadings stating the finding:
❌ "Analysis of FOXO4 expression" (descriptive - avoid) ✅ "FOXO4 Is Selectively Upregulated in Senescent Cells" (declarative)
To identify transcription factors regulating senescent cell viability, we
performed RNA sequencing on proliferating and senescent human fibroblasts
(IMR90 cells induced to senesce by replicative exhaustion, ionizing
radiation, or oncogene-induced senescence). Differential expression
analysis revealed 47 transcription factors significantly upregulated
across all senescence modalities (FDR < 0.05, fold change > 2; Figure 1A
and Table S1). Among these, FOXO4 showed the highest and most consistent
upregulation (12.3 ± 2.1-fold; Figure 1B), a finding we confirmed by
quantitative RT-PCR (Figure 1C) and immunoblot analysis (Figure 1D).
Immunofluorescence microscopy revealed nuclear FOXO4 accumulation in
senescent but not proliferating cells (Figure 1E,F).
Cell discussions are thorough and mechanistic:
Paragraph 1: Summary
Paragraphs 2-4: Mechanistic Interpretation
Paragraph 5: Comparison with Literature
Paragraph 6: Implications and Applications
Paragraph 7: Limitations
Final Paragraph: Conclusions
Cell uses a structured STAR Methods section:
RESOURCE AVAILABILITY
Lead Contact
Materials Availability
Data and Code Availability
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines
Animals
Human Subjects
METHOD DETAILS
[Detailed protocols for each technique]
QUANTIFICATION AND STATISTICAL ANALYSIS
Cell requires a comprehensive table of all key resources:
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Antibodies | ||
| Rabbit anti-FOXO4 | Abcam | Cat#ab12345 |
| Chemicals | ||
| Doxorubicin | Sigma-Aldrich | Cat#D1515 |
| Cell Lines | ||
| IMR90 | ATCC | CCL-186 |
Cell papers are figure-heavy with extensive multi-panel figures:
Panels labeled with lowercase letters: (A), (B), (C)
Figure 3. FOXO4 Sequesters p53 in the Nucleus of Senescent Cells
(A) Immunofluorescence microscopy of p53 (green) and FOXO4 (red) in
proliferating (left) and senescent (right) IMR90 cells. DAPI (blue)
marks nuclei. Scale bar, 10 μm.
(B) Quantification of nuclear p53 intensity in proliferating versus
senescent cells. Data represent mean ± SEM; n = 3 biological replicates,
>100 cells per condition. ***p < 0.001, two-tailed Student's t test.
(C and D) Co-immunoprecipitation of FOXO4 and p53 in proliferating (C)
and senescent (D) cell lysates. IgG, immunoglobulin G control.
(E) Proximity ligation assay for FOXO4-p53 interaction. Red dots indicate
interaction events. Scale bar, 10 μm.
(F) Model of FOXO4-mediated p53 sequestration in senescent cells.
See also Figure S3 and Table S2.
Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G.,
van de Sluis, B., Kirkland, J.L., and van Deursen, J.M. (2011). Clearance
of p16Ink4a-positive senescent cells delays ageing-associated disorders.
Nature 479, 232–236.
| Journal | Focus | Article Length | Figures |
|---|---|---|---|
| Cell | Breakthrough biology | Long | 7-8 main + ED |
| Neuron | Neuroscience | Long | 6-8 main |
| Immunity | Immunology | Medium-Long | 6-7 main |
| Molecular Cell | Molecular mechanisms | Medium | 5-7 main |
| Developmental Cell | Development | Medium | 5-7 main |
| Cell Reports | Solid science | Medium | 4-6 main |
venue_writing_styles.md - Master style overviewjournals_formatting.md - Technical formatting requirementsnature_science_style.md - Comparison with Nature/Science style